UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 433

Sortiert nach

Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects

Acta neurologica Scandinavica, 2010-04, Vol.121 (4), p.257-264

2010

Link zum Volltext

Verfügbarkeit prüfen

Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

The New England journal of medicine, 1998-08, Vol.339 (7), p.424-428

1998

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and penetrance of BRCA1 and BRCA2 gene Mutations in unselected Ashkenazi Jewish women with breast cancer

JNCI : Journal of the National Cancer Institute, 1999-07, Vol.91 (14), p.1241-1247

1999

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

The Lancet (British edition), 1999-11, Vol.354 (9193), p.1846-1850

1999

Link zum Volltext

Verfügbarkeit prüfen

Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment

Annals of oncology, 2005-05, Vol.16 (5), p.735-742

2005

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

American journal of human genetics, 2000-04, Vol.66 (4), p.1259-1272

2000

Link zum Volltext

Verfügbarkeit prüfen

Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer

Journal of clinical pathology, 2009-02, Vol.62 (2), p.139-146

2009

Link zum Volltext

Verfügbarkeit prüfen

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome

Annals of oncology, 2000-03, Vol.11 (3), p.307-313

2000

Link zum Volltext

Verfügbarkeit prüfen

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

British journal of cancer, 2003-09, Vol.89 (6), p.1031-1034

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of Smoking on Breast Cancer in Carriers of Mutant BRCA1 or BRCA2 Genes

JNCI : Journal of the National Cancer Institute, 1998-05, Vol.90 (10), p.761-765

1998

Link zum Volltext

Verfügbarkeit prüfen

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history

Cancer research (Chicago, Ill.), 2001-07, Vol.61 (14), p.5420-5424

2001

Link zum Volltext

Verfügbarkeit prüfen

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4045-4052

2000

Link zum Volltext

Verfügbarkeit prüfen

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer

Clinical cancer research, 1997-12, Vol.3 (12), p.2465-2469

1997

Link zum Volltext

Verfügbarkeit prüfen

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

British Journal of Cancer, 1999-09, Vol.81 (1), p.179-183

1999

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for familial and sporadic ovarian cancer among French Canadians: A case-control study

American journal of obstetrics and gynecology, 1998-08, Vol.179 (2), p.403-410

1998

Link zum Volltext

Verfügbarkeit prüfen

Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study

Journal of medical genetics, 2002-06, Vol.39 (6), p.407-409

2002

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma

Cancer, 2003-10, Vol.98 (8), p.1569-1577

2003

Link zum Volltext

Verfügbarkeit prüfen

Ratio of female to male offspring of women tested for BRCA1 and BRCA2 mutations

Journal of medical genetics, 2004-08, Vol.41 (8), p.e103-e103

2004

Link zum Volltext

Verfügbarkeit prüfen

Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: A case‐control study

International journal of cancer, 1995-12, Vol.63 (6), p.769-773

1995

Link zum Volltext

Verfügbarkeit prüfen

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer

British journal of cancer, 1999-11, Vol.81 (5), p.850-854

1999

Link zum Volltext

Verfügbarkeit prüfen

Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study

BMJ (Online), 1996-09, Vol.313 (7059), p.716

1996

Link zum Volltext

Verfügbarkeit prüfen

Genetic implications of double primary cancers of the colorectum and endometrium

Journal of medical genetics, 1998-12, Vol.35 (12), p.978-984

1998

Link zum Volltext

Verfügbarkeit prüfen

The Importance of a Family History of Breast Cancer in Predicting the Presence of a BRCA Mutation

American journal of human genetics, 1999-12, Vol.65 (6), p.1776-1778

1999

Link zum Volltext

Verfügbarkeit prüfen

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi jews

Cancer research (Chicago, Ill.), 1998-07, Vol.58 (14), p.2919-2922

1998

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status

JNCI : Journal of the National Cancer Institute, 2002-10, Vol.94 (19), p.1504-1506

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 433

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(392)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects

Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

Prevalence and penetrance of BRCA1 and BRCA2 gene Mutations in unselected Ashkenazi Jewish women with breast cancer

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment

BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

Effect of Smoking on Breast Cancer in Carriers of Mutant BRCA1 or BRCA2 Genes

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

Risk factors for familial and sporadic ovarian cancer among French Canadians: A case-control study

Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma

Ratio of female to male offspring of women tested for BRCA1 and BRCA2 mutations

Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: A case‐control study

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer

Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study

Genetic implications of double primary cancers of the colorectum and endometrium

The Importance of a Family History of Breast Cancer in Predicting the Presence of a BRCA Mutation

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi jews

Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status

Suchergebnisse filtern